Best of BS Opinion: Climate change summit, pandemic mismanagement, and more
Here are the best of Business Standard's opinion pieces for Monday
)
premium
Last week, with the second wave of Covid-19 ravaging the country, the government belatedly announced steps to increase the supply of vaccines, expanding access to those above 18 years, and allowing states and the private sector to buy directly from manufacturers. The moves, though long overdue, have provoked protests from opposition parties principally at the manufacturers charging a higher price for vaccines they supply to the states and a still higher one for private hospitals. This criticism does not stand up to scrutiny, writes Mihir Sharma. With the government programme creaking under the strain, private health care must come to the rescue, and it will only do so at scale if it is not a money-losing enterprise, he points out here.